146 related articles for article (PubMed ID: 21945444)
1. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K
Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444
[TBL] [Abstract][Full Text] [Related]
2. Localization of the anti-cancer peptide EGFR-lytic hybrid peptide in human pancreatic cancer BxPC-3 cells by immunocytochemistry.
Ohara K; Kohno M; Kawakami K
J Pept Sci; 2013 Aug; 19(8):511-5. PubMed ID: 23813780
[TBL] [Abstract][Full Text] [Related]
3. A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity.
Tada N; Horibe T; Haramoto M; Ohara K; Kohno M; Kawakami K
Biochem Biophys Res Commun; 2011 Apr; 407(2):383-8. PubMed ID: 21396910
[TBL] [Abstract][Full Text] [Related]
4. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
Mazurek AM; Olbryt M
Neoplasma; 2012; 59(1):43-51. PubMed ID: 22082309
[TBL] [Abstract][Full Text] [Related]
5. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
Müller MW; Giese NA; Swiercz JM; Ceyhan GO; Esposito I; Hinz U; Büchler P; Giese T; Büchler MW; Offermanns S; Friess H
Int J Cancer; 2007 Dec; 121(11):2421-33. PubMed ID: 17631638
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the semaphorin 3A pathway in prostatic cancer.
Yacoub M; Coulon A; Celhay O; Irani J; Cussenot O; Fromont G
Histopathology; 2009 Oct; 55(4):392-8. PubMed ID: 19817889
[TBL] [Abstract][Full Text] [Related]
7. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.
Liang WC; Dennis MS; Stawicki S; Chanthery Y; Pan Q; Chen Y; Eigenbrot C; Yin J; Koch AW; Wu X; Ferrara N; Bagri A; Tessier-Lavigne M; Watts RJ; Wu Y
J Mol Biol; 2007 Feb; 366(3):815-29. PubMed ID: 17196977
[TBL] [Abstract][Full Text] [Related]
8. Characterization of antilytic peptide antibody: application for the detection of lytic-based hybrid peptide in serum samples.
Ohara K; Horibe T; Kohno M; Kawakami K
J Pept Sci; 2011 Jul; 17(7):493-8. PubMed ID: 21351323
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of neuropilin-1 and its receptors, VEGF/Semaphorin 3a, in normal and cancer cells.
Haixia D; Jingsong Z; Lei J; Hairong D; Jun W; Hang X; Weixian C
Cell Biochem Biophys; 2011 Jan; 59(1):39-47. PubMed ID: 20711684
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin and neuropilin co-expression in motoneurons sets axon sensitivity to environmental semaphorin sources during motor axon pathfinding.
Moret F; Renaudot C; Bozon M; Castellani V
Development; 2007 Dec; 134(24):4491-501. PubMed ID: 18039974
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Konjac Ceramide (kCer) Binding to Sema3A Receptor Nrp1.
Usuki S; Tamura N; Tamura T; Mukai K; Igarashi Y
J Oleo Sci; 2018 Jan; 67(1):87-94. PubMed ID: 29238029
[TBL] [Abstract][Full Text] [Related]
13. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins.
Rieger J; Wick W; Weller M
Glia; 2003 Jun; 42(4):379-89. PubMed ID: 12730958
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrix.
De Wit J; De Winter F; Klooster J; Verhaagen J
Mol Cell Neurosci; 2005 May; 29(1):40-55. PubMed ID: 15866045
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin 1 directly interacts with Fer kinase to mediate semaphorin 3A-induced death of cortical neurons.
Jiang SX; Whitehead S; Aylsworth A; Slinn J; Zurakowski B; Chan K; Li J; Hou ST
J Biol Chem; 2010 Mar; 285(13):9908-9918. PubMed ID: 20133938
[TBL] [Abstract][Full Text] [Related]
16. Selective requirements for NRP1 ligands during neurovascular patterning.
Vieira JM; Schwarz Q; Ruhrberg C
Development; 2007 May; 134(10):1833-43. PubMed ID: 17428830
[TBL] [Abstract][Full Text] [Related]
17. NRP1-mediated Sema3A signals coordinate laminar formation in the developing chick optic tectum.
Watanabe Y; Sakuma C; Yaginuma H
Development; 2014 Sep; 141(18):3572-82. PubMed ID: 25183873
[TBL] [Abstract][Full Text] [Related]
18. Autocrine semaphorin 3A signaling promotes glioblastoma dispersal.
Bagci T; Wu JK; Pfannl R; Ilag LL; Jay DG
Oncogene; 2009 Oct; 28(40):3537-50. PubMed ID: 19684614
[TBL] [Abstract][Full Text] [Related]
19. SEMA3A partially reverses VEGF effects through binding to neuropilin-1.
Palodetto B; da Silva Santos Duarte A; Rodrigues Lopes M; Adolfo Corrocher F; Roversi FM; Soares Niemann F; Priscila Vieira Ferro K; Leda Figueiredo Longhini A; Melo Campos P; Favaro P; Teresinha Olalla Saad S
Stem Cell Res; 2017 Jul; 22():70-78. PubMed ID: 28636974
[TBL] [Abstract][Full Text] [Related]
20. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
Catalano A
J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
